You are viewing an updated version (2021) of the ActiveDriverDB. To view the previous version please visit activedriverdb.org/v2020

NAT2 (NM_000015) - N-acetyltransferase 2

Arylamine N-Acetyltransferase 2

Mutations Visualisation

Protein summary

This is preferred isoform of NAT2 protein.
NAT2: arylamine N-acetyltransferase 2
Description:

This gene encodes an enzyme that functions to both activate and deactivate arylamine and hydrazine drugs and carcinogens. Polymorphisms in this gene are responsible for the N-acetylation polymorphism in which human populations segregate into rapid, intermediate, and slow acetylator phenotypes. Polymorphisms in this gene are also associated with higher incidences of cancer and drug toxicity. A second polymorphic arylamine N-acetyltransferase gene (NAT1), is located near this gene (NAT2). [provided by RefSeq, Sep 2019].

Publication Note:
This RefSeq record includes a subset of the publications that are available for this gene. Please see the Gene record to access additional publications.

Evidence data:
Transcript exon combination :: SRR5189664.54927.1, SRR5189664.65048.1 [ECO:0000332] RNAseq introns :: single sample supports all introns SAMEA1966682, SAMEA1968540 [ECO:0000348]

##RefSeq-Attributes-START## MANE Ensembl match :: ENST00000286479.4/ ENSP00000286479.3 RefSeq Select criteria :: based on conservation, expression, longest protein ##RefSeq-Attributes-END##

Strand
+
Chromosome
8
Protein
290 residues
All mutations
64
PTM sites
2
CDS
18,257,513 - 18,258,386
Transcription
18,248,754 - 18,258,723
0.0% of sequence is predicted to be disordered

External references

Mappings retrieved from NCBI & UniProt.
RefSeq
Entrez
gene: 10
UniProt
Ensembl